摘要 |
<p>The invention relates to 3,5-piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5- piperidine compound, and/or a method of treatment comprising administering a 3,5- piperidine compound, a method for the manufacture of a 3,5-piperidine compound, and novel intermediates and partial steps for their synthesis. Especially, the 3,5-piperidine compounds have the formula I, wherein the symbols have the meanings described in the specification.</p> |
申请人 |
NOVARTIS AG;NOVARTIS PHARMA GMBH;BAESCHLIN, DANIEL, KASPAR;BREITENSTEIN, WERNER;EHRHARDT, CLAUS;MAIBAUM, JUERGEN, KLAUS;OSTERMANN, NILS;ZIMMERMANN, JUERG;RUEDISSER, SIMON;VANGREVELINGHE. ERIC |
发明人 |
BAESCHLIN, DANIEL, KASPAR;BREITENSTEIN, WERNER;EHRHARDT, CLAUS;MAIBAUM, JUERGEN, KLAUS;OSTERMANN, NILS;ZIMMERMANN, JUERG;RUEDISSER, SIMON;VANGREVELINGHE. ERIC |